# Effects of Emicizumab Treatment in Patients With Hemophilia A

> **NCT07190118** · — · NOT_YET_RECRUITING · sponsor: **Hasan Kalyoncu University** · enrollment: 20 (estimated)

## Conditions studied

- Hemophilia A
- Musculoskeletal Assessment
- Musculoskeletal Abnormalities

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07190118
- **Lead sponsor:** Hasan Kalyoncu University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-30
- **Primary completion:** 2025-11-10
- **Final completion:** 2026-02-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07190118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07190118, "Effects of Emicizumab Treatment in Patients With Hemophilia A". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07190118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*